BetterLife Pharma Inc.
CSE: BETR, OTCQB: BETRF, FRA: NPAU
Company Overview
BetterLife Pharma Inc. is an emerging biotechnology company engaged in the development and commercialization of next generation psychedelic products for the treatment of mental disorders. Utilizing drug delivery platform technologies, BetterLife is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus.
Financial Highlights
$0
Revenue (ttm)
-$85,904
Gross Profit (ttm)
-$0.96
Diluted EPS (ttm)
Management Team
Dr. Ahmad Doroudian
Founder, CEO & Director
Ms. Moira Ong C.A., CPA, CA, CFA
Chief Financial Officer
Mr. Patrick Kroupa
Chief Psychedelics Officer
Mr. Justin Kirkland
Chief Psychedelics Scientist
Key Highlights
Market Capitalization
$0
Shares Outstanding
0
Shares Short (% of Float)
539,850 (0%)
Insider Ownership
26%